Botulax 100UI
Clostridium botulinum toxin type A · 100 units · lyophilised powder, single-dose vial. Manufactured by Hugel, Inc, South Korea.
$61.90
You save
Botulax 100UI is a high-purity (99%+) botulinum toxin type A from Hugel, the same formulation marketed as FDA-approved Letybo in the US. It suits face-centric treatments for glabellar lines, crow’s feet, and blepharospasm.
Professional use only. This product is intended for administration by licensed healthcare practitioners trained in the relevant anatomy and injection technique. By ordering you confirm you are authorised to purchase and handle products of this class in your jurisdiction. Availability and permitted use vary by country — please verify local regulations before ordering.
In accordance with applicable U.S. FDA regulations, this product is not available for purchase or shipment to U.S. addresses through this website. Customers in the United States should obtain botulinum toxin products through appropriately licensed and authorized U.S. distribution channels. A valid medical license or registration certificate is required to process any product-related claim.
Did you like this product? Add to favorites now and follow the product.

(+82) 10 7364 7998 Send a message on WhatsApp.
Hugel's botulinum toxin type A, and the formulation behind FDA-approved Letybo
Botulax is the botulinum toxin type A product made by Hugel, Inc, one of South Korea’s largest pharmaceutical manufacturers and one of the longest-established producers in this category. The 100-unit vial is supplied as a sterile lyophilised powder, reconstituted with preservative-free 0.9% sodium chloride immediately before use.
The same underlying formulation is marketed in the United States as Letybo (letibotulinumtoxinA-wlbg), which received FDA approval on 29 February 2024 for the temporary improvement in the appearance of moderate to severe glabellar lines. That approval followed three randomised, placebo-controlled Phase III trials — BLESS I, II and III — enrolling more than 1,000 subjects across the United States and Europe.
Two points worth being precise about. Letybo’s US approval covers glabellar lines only, not the wider range of areas practitioners treat in other markets. And a Korean-market Botulax carton is a separate registration from the US-labelled Letybo article — the formulation is shared, the approval is not. Confirm what is registered and lawfully supplied where you practise.
Hugel purifies the active substance using Size Exclusion High Performance Liquid Chromatography (SE-HPLC), a chromatographic step that separates the neurotoxin from residual process material and supports batch-to-batch consistency.
The same formulation is approved in the US as Letybo for glabellar lines, supported by three Phase III trials.
Size exclusion chromatography separates the neurotoxin from residual process material, supporting batch consistency.
Clinics commonly review patients at three to four months, with the first review often earlier for a new patient.
100 U, 200 U and 300 U share one formulation, so you can match vial size to session volume without changing product.
Why practitioners choose Botulax 100UI
Letybo, approved in the United States in February 2024 for glabellar lines, is the same underlying formulation — an unusually strong evidence base for a Korean-manufactured toxin.
Hugel uses SE-HPLC to separate the neurotoxin from residual process material, which supports consistent potency between batches.
Hugel has supplied this product internationally for well over a decade and is among the largest toxin manufacturers in South Korea.
Reconstitution volume is chosen by the injector, so one 100 U vial can be prepared at several concentrations to suit the treatment area.
Aesthetic & therapeutic applications
The indication under which this formulation holds US approval, as Letybo, is set out first. The remaining areas are commonly treated in practice, but approval status differs between markets — always work from the prescribing information registered in the country where you practise.
Temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity in adults. This is the sole indication covered by the February 2024 US approval of Letybo, and the endpoint used in the BLESS Phase III programme.
Lines at the outer eye produced by orbicularis oculi activity. Widely treated in aesthetic practice, though whether it is an approved indication for this product depends on your market — it is not covered by the US approval.
Horizontal lines across the forehead produced by frontalis activity. Dosing here is conservative by convention — the frontalis is the only elevator of the brow, so over-treatment risks brow heaviness. Not covered by the US approval; treatment is a clinical decision within your own regulatory framework.
In some markets the manufacturer’s registration extends to conditions such as blepharospasm and post-stroke upper limb spasticity. These vary considerably by country — consult the prescribing information approved where you practise.
Botulinum toxin products are prescription-only medicines. Any use outside the indications approved in your jurisdiction is a clinical decision made by the treating practitioner under their own professional judgement and local regulatory framework. Korea Filler Experts supplies the product; nothing here should be read as a recommendation to treat any medical condition.
What is inside Botulax 100UI
| Active substance | Clostridium botulinum toxin type A |
| Strength | 100 Units per vial |
| Strain | Clostridium botulinum CBFC26 |
| Stabiliser | Human serum albumin, 0.5 mg |
| Tonicity agent | Sodium chloride, 0.9 mg |
| Pharmaceutical form | Lyophilised powder for solution for injection |
| Purification | Size Exclusion High Performance Liquid Chromatography (SE-HPLC) |
| Diluent | Preservative-free 0.9% sodium chloride injection (not supplied) |
| Container | Single-use glass vial with rubber stopper and flip-off cap |
| Route | Intramuscular injection |
| Manufacturer | Hugel, Inc, South Korea |
| Regulatory class | Prescription-only medicine (professional use) |
Reading the carton
Before you accept a delivery, check four things:
- The lot / batch number on the carton matches the number printed on the vial.
- The expiry date leaves you enough working life — we do not dispatch stock with under 6 months remaining unless agreed in advance.
- The flip-off cap is intact and the vial seal has not been disturbed.
- The carton arrived cold, with the coolant pack still chilled.
Vial looks empty? The contents are freeze-dried under vacuum, so 100 units form a very thin film that is hard to see against the glass. This is expected and is not a sign of a short fill.
What each component does
- Botulinum toxin type A — the active substance. It temporarily reduces the release of acetylcholine at the neuromuscular junction, lowering activity in the injected muscle.
- Human serum albumin — stabilises the toxin protein during freeze-drying, storage and reconstitution.
- Sodium chloride — brings the reconstituted solution to a tonicity suitable for injection.
How it works
After intramuscular injection, botulinum toxin type A binds to receptors on presynaptic cholinergic nerve terminals and reduces the release of acetylcholine, the neurotransmitter that triggers muscle contraction. Activity in the injected muscle falls, and the movement producing a dynamic line decreases with it.
The effect is temporary. Nerve terminal function recovers over time, which is why treatment is repeated rather than permanent. Administered correctly by a trained practitioner, the effect remains local to the injected muscle.
How to prepare and use Botulax 100UI
Reference information for licensed practitioners. Reconstitution and administration must follow the prescribing information approved in your market and your own clinical governance procedures.
Step by step
-
Inspect the vial
It should be colourless and transparent, with a small quantity of white or pale yellow powder visible. Check the lot number and expiry date, and confirm the flip-off cap is intact.
-
Prepare the diluent
Draw the required volume of preservative-free 0.9% sterile sodium chloride into a sterile syringe. A fine-gauge needle, typically 30G, alcohol swabs and gloves should be ready.
-
Introduce the saline slowly
Insert the needle at an angle and let the vacuum draw the saline in. Direct the stream against the vial wall rather than onto the powder.
-
Mix gently
Rotate the vial slowly to dissolve the cake. Do not shake vigorously — agitation can denature the protein.
-
Confirm before drawing
The solution should be clear, colourless and free of particles. Discard the vial if it is cloudy, discoloured or contains visible matter.
-
Record and refrigerate
Note the reconstitution date and time on the vial, store at 2–8 °C, and use within the period stated in your approved prescribing information.
Dilution reference
| Diluent added | Units per 0.1 mL | Total volume |
|---|---|---|
| 1.0 mL | 10 U | 1.0 mL |
| 2.0 mL | 5 U | 2.0 mL |
| 2.5 mL | 4 U | 2.5 mL |
| 4.0 mL | 2.5 U | 4.0 mL |
| 5.0 mL | 2 U | 5.0 mL |
Administration notes
Because the powder is freeze-dried under vacuum, the vial can look nearly empty before reconstitution. This is normal and the full dose is present.
Materials needed: preservative-free 0.9% sterile saline, a sterile syringe (typically 30G), gloves and alcohol swabs. None of these are supplied with the vial.
- Units of botulinum toxin are product-specific. Do not convert or substitute units between brands — a Botulax unit is not interchangeable with a unit of any other toxin.
- Dose per site, total dose and injection technique must follow the prescribing information approved in your market.
- Draw reconstituted product immediately before injection.
- Treatment intervals should not be shortened below the minimum stated in the prescribing information.
After treatment
- Avoid rubbing or massaging the treated area for at least 24 hours
- Stay upright and avoid lying down for 4 to 6 hours
- Avoid strenuous exercise for 24 to 48 hours
- Avoid saunas, hot tubs and excessive sun exposure for at least 24 hours
- Delay facials, microdermabrasion or chemical peels for at least a week
- Mild redness, swelling or bruising can occur and usually settles within a few days
Storing and handling Botulax 100UI
Store refrigerated at 2–8 °C in the original carton, protected from light. Do not freeze. Always work to the expiry date printed on the carton.
Keep at 2–8 °C and use within the period stated in your approved prescribing information — commonly 24 hours. Do not freeze reconstituted solution. Single-patient use only.
Transfer stock into a monitored medical refrigerator on arrival and keep a temperature log. If a shipment arrives warm, photograph the packaging and contact us before putting it into clinical service.
Do not use the vial if the powder is discoloured, if the reconstituted solution is cloudy or contains particles, if the expiry date has passed, or if the cold chain is known to have been broken. Dispose of unused product and used vials as clinical waste in line with local requirements.
What's included with Botulax 100UI
Diluent (0.9% sodium chloride injection), syringes and needles are not supplied with this product and must be sourced separately.
Botulax 100UI — frequently asked questions
What is Botulax 100UI?
Botulax 100UI is a botulinum toxin type A product manufactured by Hugel, Inc. in South Korea. It is supplied as a sterile freeze-dried powder in a single 100-unit vial and reconstituted with preservative-free 0.9% sodium chloride before injection by a licensed practitioner.
Is Botulax the same as Letybo?
They share the same underlying formulation. Letybo (letibotulinumtoxinA-wlbg) is the brand Hugel markets in the United States, where it received FDA approval on 29 February 2024 for the temporary improvement in the appearance of moderate to severe glabellar lines.
They are separate registrations. A Korean-market Botulax carton is not the FDA-approved, US-labelled Letybo article, and the US approval covers glabellar lines only. Confirm what is approved and lawfully supplied in your own country before ordering.
Why does the vial look empty?
The contents are freeze-dried under vacuum, so 100 units of active substance form a very thin, almost transparent film on the base or wall of the vial. This is normal for lyophilised toxins and is not a sign of a short fill or a counterfeit. The powder becomes obvious once saline is introduced.
How should I dilute a 100 U vial?
Dilution volume is chosen by the practitioner. Adding 2.5 mL of preservative-free 0.9% sodium chloride gives 4 units per 0.1 mL, which is a commonly used concentration; the reference table above lists other volumes. Always follow the reconstitution instructions in the prescribing information approved for your market.
How quickly does it take effect, and when should I review?
Onset is commonly reported within the first week after injection, with the effect assessed at a two to four week review. In routine aesthetic practice patients are typically seen again at three to four months. Individual response varies with dose, muscle mass, technique and treatment history, so no specific duration can be promised.
Should I order the 100 U, 200 U or 300 U vial?
All three share the same formulation, so the choice is about session volume rather than product. The 100 U vial suits face-focused treatment lists; 200 U and 300 U reduce the number of vials opened when you are treating larger muscle groups or running high-volume sessions. Reconstituted product is single-patient use, so size the vial to the session rather than the week.
Can I substitute Botulax units for another brand's units?
No. Units of botulinum toxin are specific to each product and are not interchangeable between brands. Dosing must be taken from the prescribing information for the product in your hand.
What shelf life will my stock have?
We do not dispatch stock with less than six months of remaining shelf life unless you have specifically agreed to it. If you need a particular expiry window — for a treatment programme booked months ahead, for example — tell us before you order and we will allocate accordingly.
Can I get the batch number and expiry before I order?
Yes. Ask our team and we will confirm the lot number and expiry date of the stock allocated to your order before it is dispatched.
What happens if my shipment arrives warm?
Do not use it. Photograph the outer box, the insulated liner, the coolant packs and the vial carton, and contact us the same day with your order number. We will review the cold-chain evidence and arrange a replacement where the failure occurred in transit.
Who is allowed to buy this product?
Botulinum toxin is a prescription-only medicine. Purchase and use are restricted to licensed healthcare professionals qualified to prescribe or administer injectable prescription medicines in their jurisdiction, with appropriate training in the relevant anatomy and injection technique. We do not sell to consumers.



